[HTML][HTML] Preferential expression of programmed death ligand 1 protein in tumor-associated macrophages and its potential role in immunotherapy for hepatocellular …
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular …
P Dong-Jun, PS Sung, L Gil-Won… - International …, 2021 - search.proquest.com
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
[PDF][PDF] Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular …
DJ Park, PS Sung, GW Lee, S Cho, SM Kim… - Int. J. Mol …, 2021 - researchgate.net
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular …
DJ Park, PS Sung, GW Lee, S Cho, SM Kim, BY Kang… - 2021 - agris.fao.org
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
[引用][C] Preferential Expression of Programmed Death-Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular …
DJ Park, GW Lee, SM Kim, W Hur, SK Lee… - 춘· 추계학술대회(The …, 2021 - kiss.kstudy.com
Preferential Expression of Programmed Death-Ligand 1 Protein in Tumor-Associated
Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma - 춘·추계 학술 …
Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma - 춘·추계 학술 …
[PDF][PDF] Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular …
DJ Park, PS Sung, GW Lee, S Cho, SM Kim… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular …
DJ Park, PS Sung, GW Lee, S Cho, SM Kim… - … Journal of Molecular …, 2021 - europepmc.org
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
[HTML][HTML] Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for …
DJ Park, PS Sung, GW Lee, SW Cho… - … Journal of Molecular …, 2021 - ncbi.nlm.nih.gov
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
Preferential expression of programmed death ligand 1 protein in tumor-associated macrophages and its potential role in immunotherapy for hepatocellular carcinoma
DJ Park, PS Sung, GW Lee, S Cho… - International …, 2021 - cuk.elsevierpure.com
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in hepa-
tocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we focused on …
tocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we focused on …
Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular …
DJ Park, PS Sung, GW Lee, S Cho… - International …, 2021 - pubmed.ncbi.nlm.nih.gov
A predictive biomarker of immune checkpoint inhibitor (ICI)-based treatments in
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …
hepatocellular carcinoma (HCC) has not been clearly demonstrated. In this study, we …